Go Back
Decheng Capital
Decheng Capital, established in 2012, is a venture capital firm that focuses on the healthcare sector, including biotech and medical devices. With 15 exits out of 49 investments, their significant impact in healthcare innovation is evident. Find out more at www.decheng.com.
About
About
About
Bio
Decheng Capital is a venture capital firm that provides capital to early and growth stage life science companies.
Location
Menlo Park, California
Stage
Seed
Partner name
Dayton Misfeldt
Bio
Decheng Capital is a venture capital firm that provides capital to early and growth stage life science companies.
Location
Menlo Park, California
Stage
Seed
Partner name
Dayton Misfeldt
Fund
Fund
Fund
Fund Focus
BioTech, Healthcare, Life Science, Big Data & Analytics, Medical Device, Pharmaceuticals, Advanced Materials
Number of investments
71
Number of exits
15
Fund Type
Venture Fund
Portfolio Companies
Genapsys, ACELYRIN, LevitasBio, Neurelis, Shape Therapeutics, Encodia
Decheng Capital
Decheng Capital, established in 2012, is a venture capital firm that focuses on the healthcare sector, including biotech and medical devices. With 15 exits out of 49 investments, their significant impact in healthcare innovation is evident. Find out more at www.decheng.com.
About
Bio
Decheng Capital is a venture capital firm that provides capital to early and growth stage life science companies.
Location
Menlo Park, California
Stage
Seed
Partner name
Dayton Misfeldt
Fund
Fund Focus
BioTech, Healthcare, Life Science, Big Data & Analytics, Medical Device, Pharmaceuticals, Advanced Materials
Number of investments
71
Number of exits
15
Fund Type
Venture Fund
Portfolio Companies
Genapsys, ACELYRIN, LevitasBio, Neurelis, Shape Therapeutics, Encodia